Flow cytometry analysis reveals that CAS treatment increases splenic populations of CD3+CD8+ cytotoxic T cells, CD3+CD44+ memory T cells, and NK cells, while enhancing CD8+ T cell infiltration in tumor tissue. This evidence concerns the gene CD44 and neoplasm.